David K.R. Karaolis

3.2k total citations
31 papers, 2.4k citations indexed

About

David K.R. Karaolis is a scholar working on Endocrinology, Immunology and Molecular Biology. According to data from OpenAlex, David K.R. Karaolis has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in David K.R. Karaolis's work include Vibrio bacteria research studies (15 papers), Salmonella and Campylobacter epidemiology (8 papers) and Aquaculture disease management and microbiota (7 papers). David K.R. Karaolis is often cited by papers focused on Vibrio bacteria research studies (15 papers), Salmonella and Campylobacter epidemiology (8 papers) and Aquaculture disease management and microbiota (7 papers). David K.R. Karaolis collaborates with scholars based in United States, Japan and Australia. David K.R. Karaolis's co-authors include Peter R. Reeves, James B. Kaper, Ruiting Lan, Judith A. Johnson, Yoshihiro Hayakawa, Mamoru Hyodo, Edgar C. Boedeker, Mohammed H. Rashid, Camella Bailey and Sita Somara and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

David K.R. Karaolis

31 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David K.R. Karaolis United States	22	1.2k	1.1k	852	544	451	31	2.4k
Michael W. Heuzenroeder Australia	27	1.4k 1.1×	482 0.4×	749 0.9×	617 1.1×	568 1.3×	69	2.5k
Suzana P. Salcedo France	29	1.2k 1.0×	687 0.6×	696 0.8×	693 1.3×	240 0.5×	44	2.8k
Josette Arondel France	18	1.1k 0.9×	582 0.5×	694 0.8×	305 0.6×	802 1.8×	24	2.2k
Nityananda Chowdhury United States	25	974 0.8×	599 0.5×	650 0.8×	366 0.7×	152 0.3×	45	1.9k
Masaaki Iwanaga Japan	25	2.3k 1.9×	1.1k 1.0×	579 0.7×	855 1.6×	567 1.3×	112	3.0k
James E. Bina United States	25	816 0.7×	555 0.5×	744 0.9×	227 0.4×	260 0.6×	48	2.0k
Dieter M. Schifferli United States	28	1.1k 0.9×	252 0.2×	802 0.9×	857 1.6×	484 1.1×	71	2.4k
Hirofumi Danbara Japan	25	736 0.6×	288 0.3×	432 0.5×	887 1.6×	358 0.8×	60	1.8k
Takashi Hamabata Japan	21	783 0.6×	397 0.4×	535 0.6×	570 1.0×	395 0.9×	55	1.6k
Uwe H. Stroeher Australia	26	835 0.7×	370 0.3×	619 0.7×	233 0.4×	160 0.4×	41	1.9k

Countries citing papers authored by David K.R. Karaolis

Since Specialization

Citations

This map shows the geographic impact of David K.R. Karaolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K.R. Karaolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K.R. Karaolis more than expected).

Fields of papers citing papers by David K.R. Karaolis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K.R. Karaolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K.R. Karaolis. The network helps show where David K.R. Karaolis may publish in the future.

Co-authorship network of co-authors of David K.R. Karaolis

This figure shows the co-authorship network connecting the top 25 collaborators of David K.R. Karaolis. A scholar is included among the top collaborators of David K.R. Karaolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K.R. Karaolis. David K.R. Karaolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chandra, Dinesh, Wilber Quispe‐Tintaya, Arthee Jahangir, et al.. (2014). STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer. Cancer Immunology Research. 2(9). 901–910. 201 indexed citations

Ondov, Brian, Diana Radune, Thomas Blank, et al.. (2013). Genome Sequence of the Attenuated Carbosap Vaccine Strain of Bacillus anthracis. Genome Announcements. 1(1). 5 indexed citations

Hu, Dong‐Liang, Kouji Narita, Mamoru Hyodo, et al.. (2009). c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. Vaccine. 27(35). 4867–4873. 61 indexed citations

Ogunniyi, Abiodun D., James C. Paton, Alun C. Kirby, et al.. (2008). c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. Vaccine. 26(36). 4676–4685. 65 indexed citations

Hyodo, Mamoru, Yoshihiro Hayakawa, & David K.R. Karaolis. (2006). Organic Synthesis, Chemical Properties, and Biological Activities of Cyclic bis(3'-5')Diguanylic Acid (c-di-GMP) and Its Analogs. Journal of Synthetic Organic Chemistry Japan. 64(4). 359–370. 5 indexed citations

Hyodo, Mamoru, et al.. (2005). Chemical behavior of bis(3′–5′)diguanylic acid in aqueous solutions. Nucleic Acids Symposium Series. 49(1). 117–118. 9 indexed citations

Karaolis, David K.R., Kunrong Cheng, Michael Lipsky, et al.. (2005). 3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Biochemical and Biophysical Research Communications. 329(1). 40–45. 86 indexed citations

Karaolis, David K.R., Mohammed H. Rashid, Chythanya Rajanna, et al.. (2005). c-di-GMP (3′-5′-Cyclic Diguanylic Acid) Inhibits Staphylococcus aureus Cell-Cell Interactions and Biofilm Formation. Antimicrobial Agents and Chemotherapy. 49(3). 1029–1038. 123 indexed citations

Brouillette, Éric, Mamoru Hyodo, Yoshihiro Hayakawa, David K.R. Karaolis, & François Malouin. (2005). 3′,5′-Cyclic Diguanylic Acid Reduces the Virulence of Biofilm-Forming Staphylococcus aureus Strains in a Mouse Model of Mastitis Infection. Antimicrobial Agents and Chemotherapy. 49(8). 3109–3113. 62 indexed citations

10.

Campos, Leila Carvalho, Viviane Zahner, Kátia Eliane Santos Avelar, et al.. (2004). Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance. Epidemiology and Infection. 132(5). 985–992. 23 indexed citations

11.

Rashid, Mohammed H., Chythanya Rajanna, Afsar Ali, & David K.R. Karaolis. (2003). Identification of genes involved in the switch between the smooth and rugose phenotypes ofVibrio cholerae. FEMS Microbiology Letters. 227(1). 113–119. 78 indexed citations

12.

Rashid, Mohammed H., Chythanya Rajanna, Dalin Zhang, et al.. (2003). Role of exopolysaccharide, the rugose phenotype and VpsR in the pathogenesis of epidemic Vibrio cholerae. FEMS Microbiology Letters. 230(1). 105–113. 28 indexed citations

13.

Rivera, Irma Nelly Gutierrez, et al.. (2003). Characterization of a Vibrio cholerae phage isolated from the coastal water of Peru. Environmental Microbiology. 5(5). 350–354. 10 indexed citations

14.

Zhang, Dalin, et al.. (2003). Analysis of theVibriopathogenicity island-encoded Mop protein suggests a pleiotropic role in the virulence of epidemicVibrio cholerae. FEMS Microbiology Letters. 225(2). 311–318. 9 indexed citations

15.

Rivera, Irma Nelly Gutierrez, et al.. (2002). Prevalence of virulence-associated genes in clinical and environmentalVibrio choleraestrains isolated in Brazil between 1991 and 1999. FEMS Microbiology Letters. 215(1). 15–21. 24 indexed citations

16.

Ali, Afsar, Mohammed H. Rashid, & David K.R. Karaolis. (2002). High-Frequency Rugose Exopolysaccharide Production by Vibrio cholerae. Applied and Environmental Microbiology. 68(11). 5773–5778. 58 indexed citations

17.

Zhang, Dalin, et al.. (2002). The Vibrio Pathogenicity Island-Encoded Mop Protein Modulates the Pathogenesis and Reactogenicity of Epidemic Vibrio cholerae. Infection and Immunity. 71(1). 510–515. 14 indexed citations

18.

Karaolis, David K.R., Sita Somara, David R. Maneval, Judith A. Johnson, & James B. Kaper. (1999). A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature. 399(6734). 375–379. 286 indexed citations

19.

Karaolis, David K.R., Timothy K. McDaniel, James B. Kaper, & Edgar C. Boedeker. (1997). Cloning of the RDEC-1 Locus of Enterocyte Effacement (LEE) and Functional Analysis of the Phenotype on Hep-2 Cells. Advances in experimental medicine and biology. 412. 241–245. 20 indexed citations

20.

Karaolis, David K.R., Ruiting Lan, & Peter R. Reeves. (1995). The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae. Journal of Bacteriology. 177(11). 3191–3198. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact